EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeted Modulation of the Gut Microbiota in Obesity: From Dietary Interventions to Bacteriophage-Based Precision Therapies

Sthefhany Nohemí Rodríguez-Arellano iD, Jean Pierre González-Gómez iD, José Roberto Aguirre-Sánchez iD, Bruno Gomez-Gil iD, Elisa Barrón-Cabrera iD, Cristobal Chaidez iD, Marcela de Jesús Vergara-Jiménez

Nutrients · 25.10.2026 · 18 (21) · 3508

DOI: 10.3390/nu18213508 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 25.10.2026. Verfasst von Sthefhany Nohemí Rodríguez-Arellano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ciencias de la Nutrición y Gastronomía, Universidad Autónoma de Sinaloa, Culiacan 80019, Sinaloa, Mexico. Hauptthemen laut MEDLINE: Obesity, Gastrointestinal Microbiome, Bacteriophages, Phage Therapy. Die Arbeit nennt 235 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a complex chronic disease associated with metabolic and inflammatory alterations in which the gut microbiota has emerged as an important contributing factor. Obesity-associated gut dysbiosis involves not only changes in microbial composition but also alterations in microbial functions and metabolites that may affect intestinal barrier integrity, immune regulation, adipose tissue metabolism, insulin sensitivity, and glucose homeostasis. Current microbiota-modulating strategies, including dietary interventions, prebiotics, probiotics, synbiotics, and fecal microbiota transplantation, can influence the gut microbial ecosystem; however, their effects are often highly variable among individuals and generally lack the specificity required to selectively target disease-associated bacterial populations. These limitations have increased interest in precision microbiota modulation, which aims to selectively modify microbial populations, functions, or products while minimizing unnecessary alterations to the remaining microbial community. In this context, bacteriophages represent a promising biological tool because of their ability to specifically target bacterial hosts, offering the possibility of selectively reducing bacterial populations associated with obesity-related metabolic and inflammatory disturbances. Experimental studies and early human trials have shown that bacteriophage-based interventions can modulate gut microbial communities and influence inflammatory responses, supporting their potential relevance to obesity-associated chronic low-grade inflammation. However, no published clinical trials specifically evaluating targeted bacteriophage therapy for obesity treatment were identified, and its efficacy for obesity management remains unestablished. Further research is needed to identify and validate bacterial targets, optimize phage selection and cocktail design, and evaluate phage stability, bacterial resistance, immunomodulatory effects, safety, and host–microbiota interactions before clinical translation can be considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityGastrointestinal MicrobiomeBacteriophagesPhage TherapyPrecision MedicineHumansDysbiosisPrebioticsProbioticsAnimalsFecal Microbiota TransplantationInflammation

Stichwörter der Autor:innen

gut dysbiosisgut microbiotainflammationobesityphage therapyprecision microbiome modulation

Substanzen

Prebiotics

Autor:innen und Institutionen

  • Facultad de Ciencias de la Nutrición y Gastronomía, Universidad Autónoma de Sinaloa, Culiacan 80019, Sinaloa, Mexico.
  • Laboratorio Nacional para la Investigación en Inocuidad Alimentaria (LANIIA), Centro de Investigación en Alimentación y Desarrollo, A.C. (CIAD), Culiacan 80110, Sinaloa, Mexico.
  • Centro de Inteligencia Artificial Aplicada e Innovación Tecnológica, Universidad Autónoma de Sinaloa, Culiacan 80019, Sinaloa, Mexico.
  • Centro de Investigación en Alimentación y Desarrollo, A.C. (CIAD), Unidad Mazatlán en Acuicultura y Manejo Ambiental, Mazatlan 82112, Sinaloa, Mexico.

ORCID-Profile: Sthefhany Nohemí Rodríguez-Arellano, Jean Pierre González-Gómez, José Roberto Aguirre-Sánchez, Bruno Gomez-Gil, Elisa Barrón-Cabrera, Cristobal Chaidez

Zitieren

APA

Rodríguez-Arellano, S. N., González-Gómez, J. P., Aguirre-Sánchez, J. R., Gomez-Gil, B., Barrón-Cabrera, E., Chaidez, C., & Vergara-Jiménez, M. J. (2026). Targeted Modulation of the Gut Microbiota in Obesity: From Dietary Interventions to Bacteriophage-Based Precision Therapies. Nutrients, 18(21), 3508. https://doi.org/10.3390/nu18213508

Vancouver

Rodríguez-Arellano SN, González-Gómez JP, Aguirre-Sánchez JR, Gomez-Gil B, Barrón-Cabrera E, Chaidez C, et al. Targeted Modulation of the Gut Microbiota in Obesity: From Dietary Interventions to Bacteriophage-Based Precision Therapies. Nutrients. 2026;18(21):3508. doi:10.3390/nu18213508

BibTeX
@article{RodrguezArellano2026,
  author = {Rodríguez-Arellano, Sthefhany Nohemí and González-Gómez, Jean Pierre and Aguirre-Sánchez, José Roberto and Gomez-Gil, Bruno and Barrón-Cabrera, Elisa and Chaidez, Cristobal and Vergara-Jiménez, Marcela de Jesús},
  title = {Targeted Modulation of the Gut Microbiota in Obesity: From Dietary Interventions to Bacteriophage-Based Precision Therapies},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {21},
  pages = {3508},
  doi = {10.3390/nu18213508}
}
Kostenlos starten →